KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) EBIT Margin (2016 - 2025)

Cvs Health (CVS) has disclosed EBIT Margin for 17 consecutive years, with 1.26% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 49.0% year-over-year to 1.26%, compared with a TTM value of 1.16% through Dec 2025, down 40.0%, and an annual FY2025 reading of 1.16%, up 58.0% over the prior year.
  • EBIT Margin was 1.26% for Q4 2025 at Cvs Health, down from 1.87% in the prior quarter.
  • Across five years, EBIT Margin topped out at 23.02% in Q4 2023 and bottomed at 1.68% in Q4 2021.
  • Average EBIT Margin over 5 years is 2.78%, with a median of 1.02% recorded in 2023.
  • The sharpest move saw EBIT Margin soared 2323bps in 2023, then tumbled -2225bps in 2024.
  • Year by year, EBIT Margin stood at 1.68% in 2021, then skyrocketed by 87bps to 0.21% in 2022, then soared by 11027bps to 23.02% in 2023, then crashed by -97bps to 0.77% in 2024, then surged by 63bps to 1.26% in 2025.
  • Business Quant data shows EBIT Margin for CVS at 1.26% in Q4 2025, 1.87% in Q3 2025, and 1.42% in Q2 2025.